You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 81 No. 2, August 1960 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (11)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Studies in Myasthenia Gravis

Improved Techniques in Thymectomy

ISADORE KREEL, M.D.; GABRIEL GENKINS, M.D.; KERMIT E. OSSERMAN, M.D.; ELLIOTT JACOBSON, M.D.; IVAN D. BARONOFSKY, M.D., Ph.D.

AMA Arch Surg. 1960;81(2):251-258.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

With the availability of the newer techniques and advances in surgery and anesthesia, the modern surgeon has been called upon to operate on more and more groups of patients whose medical disease presents formidable operative risks. No single group of subjects exemplifies this better than the myasthenic patient undergoing thymectomy. While the indications and selections for the operative approach in myasthenia gravis are still being modified,1-4 these patients are being operated upon in an effort to increase patient salvage in the group with this syndrome. This controversy will not be presented here, but it is pertinent to mention that a certain proportion of the myasthenic population merits special consideration apart from the existence of their disorder. Recent data5 indicate that in the myasthenic patient with thymoma, this tumor has a far higher malignant potential than was previously reported. Castleman6 found an incidence of 25% malignancy in thymoma. . . . [Full Text PDF of this Article]


Author Affiliations

New York

From the Myasthenia Gravis Clinic and the Departments of Medicine, Surgery and Anesthesiology of The Mount Sinai Hospital.; Coordinator, Department of Surgery, National Heart Trainee, National Institutes of Health, U.S. Public Health Service (Dr. Kreel). Dr. Sara Welt Fellow-In-Medicine (Dr. Genkins).


Footnotes

Aided in part by Grant from The Myasthenia Gravis Foundation, Inc.

Read at the 17th Annual Meeting of the Central Surgical Association, Chicago, Feb. 19, 1960.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1960 American Medical Association. All Rights Reserved.